Pharmacogenomics Journals Impact Factor
Pharmacogenomics is that the study of how genes affect a person’s response to drugs.
Many drugs that are currently available are “one size fits all,” but they do not work an equivalent way for everybody. It is often difficult to predict who will enjoy a medicine, who won't respond in the least, and who will experience negative side effects (called adverse drug reactions). Adverse drug reactions are a significant cause of hospitalizations and deaths in the United States. These genetic differences are going to be wont to predict whether a medicine is going to be effective for a specific person and to assist prevent adverse drug reactions. Autosomal dominant disease, Stevens-Johnson syndrome/toxic epidermal necrolysis, and thiopurine S-methyltransferase deficiency. Pharmacogenomics is that the study of how genomic variation affects a patient’s response to a specific medication. For years, researchers have mapped drug response phenotypes to individual genotypes. Pharmacogenomic associations are so strong, that they alone affect the utilization of a specific medication are rare. However, the amount of pharmacogenomic associations which will be factored into the prescribing process alongside a mess of clinical variables is growing. Pharmacogenomics focuses on the identification of genome variants that influence drug effects, typically via alterations in a drug’s pharmacokinetics (i.e., absorption, distribution, metabolism, elimination) or via modulation of a drug’s pharmacodynamics (e.g., modifying a drug’s target or perturbing biological pathways that alter sensitivity to the drug’s pharmacological effects). For infectious diseases, genomic variation in the infectious agents themselves may alter their sensitivity to antimicrobials. Advances in genome interrogation technology and in analytical approaches have facilitated evolution of the discovery paradigm from candidate gene studies to more agnostic genome wide analyses of populations of patients who have been characterized for specific drug response phenotypes (e.g., toxicity or desired pharmacologic effects)
High Impact List of Articles
-
Editorial Highlights for Pharmacoeconomics: Open Access
Kenneth Stokes Editorial: Pharmacoeconomics: Open Access
-
Editorial Highlights for Pharmacoeconomics: Open Access
Kenneth Stokes Editorial: Pharmacoeconomics: Open Access
-
Market Analysis of Pharmaceuticals - Medicine-Pharma-2020
James Okeya Market Analysis: Pharmacoeconomics: Open Access
-
Market Analysis of Pharmaceuticals - Medicine-Pharma-2020
James Okeya Market Analysis: Pharmacoeconomics: Open Access
-
Using Real-World Data to Estimate the Social Security Costs of Retinal Diseases: Results from the Observatory on Legal Blindness
Mennini FS, Trabucco Aurilio M, Russo S, Migliorini R, Massimo Piccioni and Ricci F
Research Article: Pharmacoeconomics: Open Access
-
Using Real-World Data to Estimate the Social Security Costs of Retinal Diseases: Results from the Observatory on Legal Blindness
Mennini FS, Trabucco Aurilio M, Russo S, Migliorini R, Massimo Piccioni and Ricci F
Research Article: Pharmacoeconomics: Open Access
-
A Systematic Literature Review and Critical Appraisal of Economic Modelling Approaches of Pharmacologic Interventions for Systemic Lupus Erythematosus (SLE)
Tolley K, Cranmer H, Desta B, Tummala R and Tafesse E
Review Article: Pharmacoeconomics: Open Access
-
A Systematic Literature Review and Critical Appraisal of Economic Modelling Approaches of Pharmacologic Interventions for Systemic Lupus Erythematosus (SLE)
Tolley K, Cranmer H, Desta B, Tummala R and Tafesse E
Review Article: Pharmacoeconomics: Open Access
-
Impact of the Recent Changes in the Pharmacy Remuneration System in Portugal (2010-2014) – Moving from Paper to Reality
Inês Teixeira, José Pedro Guerreiro and Suzete Costa Research Article: Pharmacoeconomics: Open Access
-
Impact of the Recent Changes in the Pharmacy Remuneration System in Portugal (2010-2014) – Moving from Paper to Reality
Inês Teixeira, José Pedro Guerreiro and Suzete Costa Research Article: Pharmacoeconomics: Open Access
-
A Review of Pharmacoeconomics and a Discussion on Branded, Branded Generics and Generics
Sunitha Gangone, Divyasri Godala and Sriharsha Veena Kashetti Review: Pharmacoeconomics: Open Access
-
A Review of Pharmacoeconomics and a Discussion on Branded, Branded Generics and Generics
Sunitha Gangone, Divyasri Godala and Sriharsha Veena Kashetti Review: Pharmacoeconomics: Open Access
-
A Case Report of Prototheca Meningitis in China
Li YT, Zeng YF, Ning G, Gan WQ and Lin CS Case Report: Pharmacoeconomics: Open Access
-
A Case Report of Prototheca Meningitis in China
Li YT, Zeng YF, Ning G, Gan WQ and Lin CS Case Report: Pharmacoeconomics: Open Access
-
Economic Evaluation of Omalizumab in the Treatment of Severe AllergicAsthma in Adult Patients in Greece: A Cost Effectiveness Analysis ofClinical Trial and Real-Life Data
Venkateshwarlu Sonathi, Magdalini Hatzikou, Mary Geitona, Mike Baldwin, Elena Panitti and Nikolaos Siafakas Research Article: Pharmacoeconomics: Open Access
-
Economic Evaluation of Omalizumab in the Treatment of Severe AllergicAsthma in Adult Patients in Greece: A Cost Effectiveness Analysis ofClinical Trial and Real-Life Data
Venkateshwarlu Sonathi, Magdalini Hatzikou, Mary Geitona, Mike Baldwin, Elena Panitti and Nikolaos Siafakas Research Article: Pharmacoeconomics: Open Access
Conference Proceedings
-
Electrohydrodynamic atomization technologies for the preparation of fibrous NSAID buccal films
Kazem Nazari Posters & Accepted Abstracts: Pharmacoeconomics: Open Access
-
Electrohydrodynamic atomization technologies for the preparation of fibrous NSAID buccal films
Kazem Nazari Posters & Accepted Abstracts: Pharmacoeconomics: Open Access
-
Estimation of causal equivalence effects in clinical bioequivalence/biosimilar studies in the presence of inter current events: Noncompliance and missing data
Wanjie Sun Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
-
Estimation of causal equivalence effects in clinical bioequivalence/biosimilar studies in the presence of inter current events: Noncompliance and missing data
Wanjie Sun Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
-
Biosimilars 101 for oncology/hematology team members in Colorado
Rovshan M Ismailov and Zaytuna D Khasanova Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
-
Biosimilars 101 for oncology/hematology team members in Colorado
Rovshan M Ismailov and Zaytuna D Khasanova Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
-
Cholesterol uptake in mammalian cells supplemented with edible bird nest (EBN) extract
Mokrish Ajat, Akmal M N, Salleh F, Intan-Shameha A R, Mansor R, Aini I, Goh Y M, Ahmad H, Omar A R, Abas F and Song L K Scientific Tracks Abstracts: Journal of Bioprocessing & Biotechniques
-
Cholesterol uptake in mammalian cells supplemented with edible bird nest (EBN) extract
Mokrish Ajat, Akmal M N, Salleh F, Intan-Shameha A R, Mansor R, Aini I, Goh Y M, Ahmad H, Omar A R, Abas F and Song L K Scientific Tracks Abstracts: Journal of Bioprocessing & Biotechniques
-
Carrageenan and its potential use as a photoprotective agent: Anti-inflammatory and apoptotic cell death
Haema Thevanayagam Scientific Tracks Abstracts: Journal of Pharmacognosy & Natural Products
-
Carrageenan and its potential use as a photoprotective agent: Anti-inflammatory and apoptotic cell death
Haema Thevanayagam Scientific Tracks Abstracts: Journal of Pharmacognosy & Natural Products
-
Pharmacogenomics: The future of clinical trials, new product development and the practice of medicine
Michael Drues Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access
-
Pharmacogenomics: The future of clinical trials, new product development and the practice of medicine
Michael Drues Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access
-
Impact of pharma regulations on pharmaceutical economy
Prathyusha. A Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
-
Impact of pharma regulations on pharmaceutical economy
Prathyusha. A Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
-
Saudi pharmaceutical market: Current, future and R&D
Naser L. Rezk Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access
-
Saudi pharmaceutical market: Current, future and R&D
Naser L. Rezk Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Relevant Topics in Pharmaceutical Sciences